Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Cancer

Explore clinical trials studying Fallopian Tube Cancer. Study availability and eligibility vary by location and protocol.

330 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Cancer trial results

Recruiting

Using Aspirin to Improve Immunological Features of Ovarian Tumors

NCT05080946

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Virginia Comprehensive Cancer Center Charlottesville, Virginia, United States
  • Inova Schar Cancer Institute Fairfax, Virginia, United States
View Trial Details
Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

NCT06787612

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC San Diego Health La Jolla, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 54 locations
View Trial Details
Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366

Conditions
Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
Locations
  • USOR HonorHealth Phoenix, Arizona, United States
  • USOR Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California, San Diego; Moores Cancer Center San Diego, California, United States
View all 66 locations
View Trial Details
Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT05739981

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Johns Hopkins Medicine SKCCC Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • OU Health, Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

NCT05429970

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +32 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

NCT05377996

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +34 more
Locations
  • Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • UCLA David Geffen School of Medicine, Division of Hematology/Oncology Santa Monica, California, United States
View all 26 locations
View Trial Details
Recruiting

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

NCT05287451

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • WU St Louis St Louis, Missouri, United States
  • Mount Sinai Health System New York, United States
View Trial Details

Related conditions